Richard E. Gilbert

14.5k total citations · 2 hit papers
210 papers, 10.4k citations indexed

About

Richard E. Gilbert is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Richard E. Gilbert has authored 210 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 66 papers in Nephrology and 60 papers in Molecular Biology. Recurrent topics in Richard E. Gilbert's work include Chronic Kidney Disease and Diabetes (57 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Function and Risk Factors (23 papers). Richard E. Gilbert is often cited by papers focused on Chronic Kidney Disease and Diabetes (57 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Function and Risk Factors (23 papers). Richard E. Gilbert collaborates with scholars based in Australia, Canada and United States. Richard E. Gilbert's co-authors include Darren J. Kelly, Mark E. Cooper, Mark E. Cooper, Alison J. Cox, Henry Krum, Kim A. Connelly, Jennifer L. Wilkinson‐Berka, Kerri Thai, George Jerums and Andrew Advani and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard E. Gilbert

207 papers receiving 10.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?

1999 541 citations Richard E. Gilbert et al. Kidney International profile →
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

2019 386 citations Richard E. Gilbert, Kim A. Connelly et al. Circulation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Richard E. Gilbert	3.3k	3.1k	3.0k	2.8k	1.7k	210	10.4k
Seiya Okuda	2.1k 0.6×	1.9k 0.6×	1.5k 0.5×	2.5k 0.9×	948 0.6×	201	8.7k
Takeshi Sugaya	3.7k 1.1×	2.9k 0.9×	1.8k 0.6×	3.4k 1.2×	1.5k 0.9×	229	10.7k
Tsutomu Imaizumi	6.8k 2.1×	7.3k 2.4×	2.7k 0.9×	857 0.3×	4.8k 2.8×	350	21.1k
Katalin Suszták	8.2k 2.5×	849 0.3×	1.5k 0.5×	6.1k 2.2×	1.8k 1.1×	190	16.1k
Samir M. Parikh	3.4k 1.0×	1.6k 0.5×	499 0.2×	3.1k 1.1×	1.6k 0.9×	127	10.6k
Jitsuo Higaki	3.4k 1.1×	5.4k 1.7×	2.6k 0.9×	668 0.2×	2.5k 1.5×	422	12.7k
Joon-Keun Park	1.8k 0.6×	1.9k 0.6×	1.3k 0.4×	881 0.3×	1.8k 1.1×	74	7.1k
Chantal M. Boulanger	7.5k 2.3×	5.1k 1.6×	1.2k 0.4×	477 0.2×	1.9k 1.1×	185	16.4k
Stuart J. Shankland	6.8k 2.1×	875 0.3×	686 0.2×	8.4k 3.1×	1.5k 0.9×	229	15.2k
J.J. Emeis	1.2k 0.4×	1.6k 0.5×	1.7k 0.6×	439 0.2×	1.5k 0.9×	112	7.4k

Countries citing papers authored by Richard E. Gilbert

Since Specialization

Citations

This map shows the geographic impact of Richard E. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Gilbert more than expected).

Fields of papers citing papers by Richard E. Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Gilbert. The network helps show where Richard E. Gilbert may publish in the future.

Co-authorship network of co-authors of Richard E. Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Gilbert. A scholar is included among the top collaborators of Richard E. Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Gilbert. Richard E. Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duarte, Diego Andreazzi, Alexandros Papadimitriou, Richard E. Gilbert, et al.. (2016). Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes. PLoS ONE. 11(2). e0147978–e0147978. 15 indexed citations

Zhang, Yanling, Kerri Thai, Suzanne L. Advani, et al.. (2015). Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease. Tissue Engineering Part A. 21(13-14). 1963–1972. 1 indexed citations

Gilbert, Richard E.. (2013). Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?. Kidney International. 86(4). 693–700. 90 indexed citations

Zhang, Yuan, Amanda J. Edgley, Alison J. Cox, et al.. (2012). FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy. European Journal of Heart Failure. 14(5). 549–562. 41 indexed citations

Yuen, Darren A., Yanling Zhang, Kerri Thai, et al.. (2012). Angiogenic Dysfunction in Bone Marrow-Derived Early Outgrowth Cells from Diabetic Animals Is Attenuated by SIRT1 Activation. Stem Cells Translational Medicine. 1(12). 921–926. 20 indexed citations

Advani, Andrew, Qingling Huang, Kerri Thai, et al.. (2011). Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism. American Journal Of Pathology. 178(5). 2205–2214. 130 indexed citations

Krum, Henry, Michael Zhang, Kim A. Connelly, Richard E. Gilbert, & Darren J. Kelly. (2008). Abstract 315: Directly Targeting Myocardial Fibrosis with FT-011 Improves Cardiac Remodeling in Experimental Diabetic Cardiomyopathy. Circulation. 118. 1 indexed citations

Connelly, Kim A., Darren J. Kelly, Sandra Kim, et al.. (2008). Abstract 6248: The Direct Renin Inhibitor, Aliskiren, Improves Cardiac Function Via Direct Renin Inhibition And Via Renin Receptor Modulation In A Rodent Model Of Diabetic diastolic heart failure.. Circulation. 118. 3 indexed citations

Qi, Weier, Xinming Chen, Richard E. Gilbert, et al.. (2007). High Glucose-Induced Thioredoxin-Interacting Protein in Renal Proximal Tubule Cells Is Independent of Transforming Growth Factor-β1. American Journal Of Pathology. 171(3). 744–754. 67 indexed citations

10.

McLennan, Susan V., Darren J. Kelly, Maria Schäche, et al.. (2007). Advanced glycation end products decrease mesangial cell MMP-7: A role in matrix accumulation in diabetic nephropathy?. Kidney International. 72(4). 481–488. 45 indexed citations

11.

Connelly, Kim A., et al.. (2006). Abstract 3922: Inhibition of PKC Beta by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy. Circulation. 114. 843–843. 1 indexed citations

12.

Martín, J., Kim A. Connelly, Andrew R. Kompa, et al.. (2006). Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction: benefit of statin therapy. European Heart Journal. 27. 522–523. 1 indexed citations

13.

Gilbert, Richard E., Kim A. Connelly, Darren J. Kelly, Carol A. Pollock, & Henry Krum. (2006). Heart failure and nephropathy: Catastrophic and interrelated complications of diabetes. Journal of the American Society of Nephrology. 1(2). 1 indexed citations

14.

Wu, Qi, Xinming Chen, Stephen M. Twigg, et al.. (2006). Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney International. 69(6). 989–995. 50 indexed citations

15.

Saad, Sonia, Lesley Wassef, Philip Poronnik, et al.. (2005). High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Kidney International. 68(3). 985–997. 73 indexed citations

16.

Birtwhistle, D., et al.. (2004). An Accelerated Wet Ageing Test on Medium Voltage XLPE Cables. QUT ePrints (Queensland University of Technology). 2 indexed citations

17.

Jones, Susan, Darren J. Kelly, Alison J. Cox, et al.. (2003). Mast cell infiltration and chemokine expression in progressive renal disease1. Kidney International. 64(3). 906–913. 63 indexed citations

18.

Langham, Robyn G., Darren J. Kelly, Napier M. Thomson, et al.. (2002). Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia. 45(11). 1572–1576. 184 indexed citations

19.

Langham, Robyn G., et al.. (2001). TRANSFORMING GROWTH FACTOR-??1 AND TUMOR GROWTH FACTOR-??-INDUCIBLE GENE-H3 IN NONRENAL TRANSPLANT CYCLOSPORINE NEPHROPATHY. Transplantation. 72(11). 1826–1829. 36 indexed citations

20.

Gilbert, Richard E., et al.. (1993). Investigation of CO and H 2 adsorption on polycrystalline Pt. Journal of Physics Condensed Matter. 5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact